million
peopl
worldwid
infect
hepat
c
viru
hcv
hepatocyt
repres
major
site
viral
replic
replic
hcv
present
extrahepat
tissu
peripher
blood
mononuclear
cell
previou
studi
shown
patient
chronic
hcv
infect
develop
least
one
extrahepat
manifest
ehm
associ
hcv
mix
cryoglobulinemia
mc
first
describ
subsequ
involv
mani
organ
system
report
kidney
skin
eye
joint
nervou
system
infect
extrahepat
tissu
might
act
reservoir
hcv
play
role
hcv
persist
reactiv
infect
hcv
etiolog
agent
replic
express
viral
protein
extrahepat
tissu
contribut
ehm
associ
chronic
hcv
infect
import
featur
hcv
viru
avoid
immun
elimin
consequ
chronic
infect
accumul
circul
immunocomplex
autoimmun
phenomena
recent
cheng
et
al
demonstr
studi
among
chines
patient
ehm
mainli
includ
autoimmun
disord
mc
sjogren
syndrom
endocrinolog
diseas
autoimmun
thyroid
disord
aitd
type
diabet
hashimoto
thyroid
autoimmun
chronic
thyroid
among
common
thyroid
diseas
widespread
thyroid
form
preval
definit
frequent
femal
gender
elderli
incid
femal
gender
subject
per
year
men
lower
person
per
year
remark
variabl
differ
geograph
area
organspecif
autoimmun
diseas
morpholog
character
chronic
lymphocyt
infiltr
thyroid
presenc
circul
autoantibodi
antiperoxidas
abtpo
antithyroglobulin
abtg
inflammatori
process
lead
follicular
destruct
inde
common
caus
hypothyroid
area
iodin
suffici
occasion
thyroid
stimul
hormon
tsh
receptor
block
antibodi
respons
atroph
form
rare
antitsh
receptor
stimul
antibodi
caus
transient
form
hyperthyroid
hashitoxicosi
risk
factor
associ
numer
age
preval
diseas
tend
increas
agegenet
signific
associ
hashimoto
thyroid
histocompat
antigen
hladr
dq
allel
demonstr
mani
suscept
gene
associ
exampl
specif
gene
polymorph
link
possibl
develop
antithyroid
antibodi
iodin
increas
preval
observ
area
iodin
suffici
compar
iodinedefici
area
selenium
selenium
deficit
link
higher
preval
irradi
occur
frequent
exposur
low
dose
radiat
cytokin
treatment
interferon
ifn
interleukin
il
promot
onset
predispos
patient
infect
seen
sever
viral
infect
predispos
anim
moreov
differ
studi
tri
associ
viral
infect
human
conflict
result
first
studi
tran
et
al
report
two
case
hashimoto
thyroid
associ
chronic
activ
hcv
infect
suggest
hcv
infect
might
involv
appear
preval
hcv
infect
patient
differ
thyroid
disord
evalu
sever
studi
conflict
result
et
al
evalu
preval
hcv
infect
patient
thyroid
diseas
among
patient
simpl
goiter
none
antihcvposit
among
individu
goiter
posit
among
individu
myxedema
posit
among
patient
hashimoto
thyroid
posit
result
suggest
hcv
infect
might
associ
recent
yang
et
al
compar
person
posit
abtpo
andor
abtg
person
antibodi
neg
differ
preval
antihcv
posit
group
versu
p
found
studi
conduct
marconcini
et
al
hcv
patient
evalu
abtpo
detect
patient
wherea
abtg
detect
none
patient
conflict
result
report
earlier
studi
patient
chc
support
associ
hcv
infect
aitd
other
howev
earlier
studi
neg
lack
control
factor
may
affect
develop
thyroid
autoimmun
iodin
intak
inde
largest
studi
hcv
thyroid
iodin
defici
evalu
demonstr
hypothyroid
thyroid
autoimmun
significantli
common
patient
hcv
compar
control
preval
thyroid
disord
consecut
patient
chronic
hepat
due
hcv
infect
investig
patient
free
cirrhosi
hepatocarcinoma
interferon
treatment
three
control
group
includ
subject
iodinedefici
area
b
person
live
area
iodin
suffici
c
patient
year
age
chronic
hepat
b
level
thyroidstimul
hormon
tsh
free
free
well
abtg
abtpo
measur
mean
tsh
level
higher
p
level
lower
p
patient
chc
group
patient
chc
like
hypothyroid
n
abtg
n
abtpo
n
group
result
studi
suggest
hypothyroid
thyroid
autoimmun
common
patient
chc
even
absenc
cirrhosi
hepatocellular
carcinoma
interferon
treatment
hcvneg
control
patient
chronic
hepat
b
infect
evid
associ
also
came
studi
report
higher
preval
hypothyroid
abtg
untreat
children
chc
compar
healthi
nonhcv
infect
control
studi
examin
frequenc
thyroid
disord
patient
hcv
approxim
patient
posit
thyroid
antibodi
begin
therapi
ifn
moreov
pool
data
control
studi
hcv
infect
thyroid
autoimmun
demonstr
signific
increas
risk
thyroid
hcv
patient
larg
studi
includ
patient
infect
hcv
confirm
result
show
signific
increas
risk
thyroid
retrospect
cohort
studi
user
us
veteran
affair
health
care
facil
includ
chc
patient
least
visit
patient
uninfect
hcv
thyroid
risk
significantli
increas
hcv
patient
sinc
hcv
patient
men
well
known
male
gender
lower
risk
thyroid
femal
result
particularli
interest
presenc
higher
risk
femal
gender
increas
circul
level
abtpo
increas
risk
hypothyroid
femal
gender
abtpoposit
subject
character
pattern
thyroid
disord
observ
hcv
infect
despit
remark
therapeut
efficaci
advers
effect
wellknown
influenzalik
symptom
hematolog
effect
neuropsychiatr
symptom
thyroid
diseas
particular
previou
studi
show
femal
gender
one
common
risk
factor
predict
develop
aitd
interferon
therapi
associ
thyroid
diseas
recogn
earli
patient
treat
breast
cancer
later
sever
case
report
possibl
associ
thyroid
diseas
differ
form
ifn
induc
thyroid
autoimmun
identifi
gd
thyroid
subclin
hypothyroid
grave
hyperthyroid
less
common
type
patient
ifnrel
thyrotoxicosi
link
grave
diseas
gd
induc
circul
thyroid
receptor
antibodi
trab
interferon
induc
thyroid
iit
divid
two
main
group
autoimmun
type
nonautoimmun
type
former
manifest
ht
gd
sometim
may
relat
product
thyroid
autoantibodi
without
clinic
diseas
anoth
interest
classif
interferon
induc
hyperthyroid
propos
czarnywojtek
et
al
comparison
amiodaron
induc
thyrotoxicosi
ait
type
correspond
type
amiodaron
induc
thyrotoxicosi
ait
gt
without
tao
b
gt
tao
mild
sever
ii
type
destruct
thyrotoxicosi
partial
analog
type
ii
ait
asymptomat
silent
thyroid
b
symptomat
iii
type
unknown
aetiolog
partial
analog
type
iii
mix
presenc
thyroid
autoantibodi
initi
therapi
import
risk
factor
develop
iit
hcvposit
individu
progress
toward
hypothyroid
thyroid
autoantibodi
posit
patient
undergo
treatment
often
associ
increas
antibodi
titer
furthermor
prummel
laurberg
show
posit
pretreat
abtpo
import
risk
factor
develop
thyroid
dysfunct
also
obviou
link
femal
sex
old
age
genet
predisposit
develop
antibodi
anecdot
studi
evalu
aitd
patient
cryoglobulinemia
casecontrol
prospect
studi
conduct
evalu
thyroid
disord
mc
hcv
patient
match
sex
age
year
patient
chc
without
mc
healthi
hcvneg
control
local
popul
follow
thyroid
autoimmun
abnorm
significantli
frequent
mc
hcv
patient
hcvneg
control
serum
abtpo
level
versu
serum
abtpo
andor
abtg
level
versu
versu
subclin
hypothyroid
versu
serum
abtpo
also
significantli
frequent
mc
hcv
patient
chc
control
versu
higher
preval
thyroid
disord
patient
mc
hcv
respect
control
also
respect
hcv
patient
without
cryoglobulinemia
shown
suggest
care
monitor
thyroid
function
patient
presenc
higher
risk
hypothyroid
increas
circul
level
abtpo
femal
gender
character
pattern
thyroid
disord
observ
mc
hcv
infect
similarli
hcv
patient
without
mc
high
preval
papillari
thyroid
cancer
ptc
first
observ
hcv
patient
case
observ
control
subject
longterm
resid
iodinedefici
area
subsequ
confirm
studi
montella
et
al
carri
casecontrol
studi
differ
oncolog
patholog
screen
patient
differ
type
cancer
case
liver
cancer
multipl
myeloma
nonhodgkin
lymphoma
thyroid
cancer
case
hodgkin
diseas
control
patient
histori
cancer
relationship
cancer
hcv
infect
assess
mean
odd
ratio
correspond
confid
interv
risk
greater
liver
cancer
ci
p
multipl
myeloma
ci
p
bcell
nonhodgkin
lymphoma
ci
p
hodgkin
diseas
signific
associ
p
associ
hcv
thyroid
cancer
note
ci
p
preval
thyroid
cancer
also
investig
seri
unselect
mc
hcv
patient
comparison
gender
agematch
control
group
obtain
sampl
gener
popul
subject
preval
thyroid
nodul
higher
control
subject
mc
hcv
patient
versu
even
though
significantli
two
patient
ptc
found
mc
hcv
seri
case
observ
among
control
p
lymphocyt
infiltr
observ
thyroid
tissu
mc
hcv
patient
ptc
studi
confirm
associ
thyroid
cancer
accordingli
featur
observ
frequent
hcv
patient
control
suggest
may
predispos
condit
thyroid
cancer
sinc
hcv
patient
may
show
aggress
diseas
exampl
lung
metastas
difficult
treat
find
increas
preval
thyroid
cancer
patient
clinic
relev
sever
molecular
mechan
suggest
associ
chc
molecular
mimicri
crossreact
may
occur
viral
antigen
thyroid
antigen
b
heat
shock
protein
express
thyroid
gland
c
abnorm
express
mhc
class
ii
molecul
thyrocyt
increas
express
induc
chemokin
particular
cxc
motif
ligand
chemokin
shown
hepatocyt
lymphocyt
hcv
infect
patient
directli
relat
degre
inflamm
increas
circul
level
one
chemokin
cxc
motif
activ
specif
receptor
g
proteincoupl
receptor
seven
transmembran
domain
mainli
express
activ
lymphocyt
naturalkil
cell
nk
macrophag
b
cell
recent
studi
show
express
serum
andor
tissu
level
increas
autoimmun
organspecif
diseas
type
diabet
system
rheumatolog
diseas
like
rheumatoid
arthriti
system
lupu
erythematosu
system
sclerosi
sarcoidosi
psoriat
arthriti
high
level
present
patient
particular
presenc
hypothyroid
involv
thelper
th
immun
respons
induct
gd
grave
ophthalmopathi
demonstr
suggest
intrathyroid
lymphocyt
andor
thyrocyt
may
sourc
furthermor
presenc
hcv
thyroid
chronic
infect
patient
recent
shown
abovement
base
specul
hcv
thyroid
infect
may
act
upregul
gene
express
secret
thyrocyt
recruit
lymphocyt
secret
tumor
necrosi
factor
tnf
cytokin
induc
secret
thyrocyt
thu
perpetu
immun
cascad
may
lead
appear
aitd
genet
predispos
subject
figur
recent
find
high
serum
level
normal
level
prototyp
chemokin
cc
motif
ligand
mc
hcv
patient
comparison
patient
without
thyroid
confirm
hypothesi
data
suggest
chemokin
specif
link
appear
patient
serum
assay
mc
hcv
patient
patient
mc
mc
control
without
control
control
significantli
higher
control
control
p
mc
control
mc
control
mc
p
high
level
mean
sd
control
pgml
present
control
control
mc
mc
p
significantli
higher
mc
mc
control
control
p
high
level
mean
sd
control
pgml
present
control
control
mc
mc
p
among
proinflammatori
cytokin
associ
presenc
mc
hcv
patient
modestli
significantli
increas
patient
whole
agreement
observ
autoimmun
disord
report
data
underlin
import
activ
immun
initi
patient
mc
hcv
conclus
abovement
result
show
high
preval
aitd
patient
chc
infect
presenc
higher
risk
femal
gender
increas
circul
level
abtpo
increas
risk
hypothyroid
femal
gender
abtpoposit
subject
character
pattern
thyroid
disord
observ
hcv
infect
hcv
patient
thyroid
cancer
thyroidectomi
requir
appropri
radioiodin
treatment
patient
hcv
infect
aitd
nodul
occur
fine
needl
aspir
biopsi
without
neoplast
process
requir
care
observ
